Anastasia Wyce

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study”.

Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study

International Journal of Cancer(2021)10.1002/ijc.33861

N/A

1.9DataRank · unranked

62 citations

Jean‐Yves Blay, Irene García, Johann S. De Bono, Christophe Le Tourneau, Víctor Moreno +25 more

Limited antitumor activity of combined BET and MEK inhibition in neuroblastoma

Pediatric Blood & Cancer(2020)10.1002/pbc.28267

N/A

0.925DataRank · unranked

21 citations

Lori S. Hart, Alexander L. Shazad, Maria Gagliardi, Matthew Tsang, Jimmy Elias +11 more

H2B Ubiquitylation Acts as a Barrier to Ctk1 Nucleosomal Recruitment Prior to Removal by Ubp8 within a SAGA-Related Complex

UNC Libraries(2021)10.17615/5gjr-1h75

N/A

0DataRank · unranked

0 citations

Wendy Walter, Shelley L. Berger, Nevan J. Krogan, Anastasia Wyce, Dirk Eick +5 more